Astrana Health (ASTH) closed at $36.53 on October 30, 2026, down 0.2% from the previous close, on volume of 211,442 shares (30-day average 351,524).
Data as of October 30, 2026.
30-Oct-2026
PRNewswire (Thu, 15-Oct 10:02 AM ET)
Verda Healthcare, Inc. and AstranaCare Partners Form a Multi-State Partnership
Business Wire (Sat, 10-Oct 3:05 PM ET)
Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call
PRNewswire (Fri, 9-Oct 4:06 PM ET)
Globe Newswire (Tue, 29-Sep 4:59 PM ET)
ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law
Business Wire (Tue, 29-Sep 8:06 AM ET)
Globe Newswire (Tue, 22-Sep 10:35 AM ET)
Astrana Health, Inc. Reports Second Quarter 2026 Results
PRNewswire (Thu, 6-Aug 4:05 PM ET)
ASTH to Spotlight AI-Driven Care Model at Five Major Investor Conferences in March
Market Chameleon (Wed, 4-Mar 4:30 AM ET)
Market Chameleon (Mon, 2-Mar 6:14 AM ET)
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
Astrana Health trades on the NASDAQ stock market under the symbol ASTH.
As of October 30, 2026, ASTH stock price declined to $36.53 with 211,442 million shares trading.
ASTH has a beta of 1.19, meaning it tends to be more sensitive to market movements. ASTH has a correlation of 0.06 to the broad based SPY ETF.
ASTH has a market cap of $1.81 billion. This is considered a Small Cap stock.
Last quarter Astrana Health reported $973 million in Revenue and $.40 earnings per share. This fell short of revenue expectation by $-12 million and missed earnings estimates by -$.25.
The top ETF exchange traded funds that ASTH belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.
ASTH has outperformed the market in the last year with a price return of +14.8% while the SPY ETF gained +12.3%. However, in the short term, ASTH had mixed performance relative to the market. It has underperformed in the last 3 months, returning -0.4% vs +2.1% return in SPY. But in the last 2 weeks, ASTH shares have fared better than the market returning -0.8% compared to SPY -1.0%.
ASTH support price is $35.65 and resistance is $37.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASTH shares will trade within this expected range on the day.
